The Impact of COVID-19 Infection on Abdominal Aortic Aneurysms: Mechanisms and Clinical Implications

Overview

Journal Cardiovasc Ther

Publisher Hindawi

Date 2025 Jan 1

PMID 39742024

Authors

Zenghan Cao

Jianhang Gao

Jianqiang Wu

Yuehong Zheng

Affiliations

Soon will be listed here.

Abstract

The COVID-19 virus not only has significant pathogenicity but also influences the progression of many diseases, altering patient prognosis. Cardiovascular diseases, particularly aortic aneurysms, are among the most life-threatening conditions. COVID-19 infection is reported to accelerate the progression of abdominal aortic aneurysms (AAAs) and increase the risk of rupture; however, a comprehensive understanding of the underlying mechanisms remains elusive. This article primarily reviews the relevant foundational research, focusing on disruptions in the renin-angiotensin-aldosterone system (RAAS), immune system activation, and coagulation disorders. Furthermore, we summarize related clinical research, including the epidemiology of aortic aneurysms during the pandemic and specific case studies. COVID-19 infection can influence the onset and progression of aortic aneurysms by affecting the RAAS, triggering inflammation and immune dysregulation in the arterial wall, and inducing a hypercoagulation state. It is crucial to comprehensively understand the impact of pandemic viral infections on aortic diseases at the foundational and clinical levels, thereby identifying potential preventative or therapeutic approaches and preparing for potential future outbreaks.

References

Sun C, Han Y, Zhang R, Liu S, Wang J, Zhang Y . Regulated necrosis in COVID-19: A double-edged sword. Front Immunol. 2022; 13:917141. PMC: 9452688. DOI: 10.3389/fimmu.2022.917141. View

Li Z, Qi M, Zhao G, Li L, Zhang H, Liu C . Managing Emergent Surgery for Ruptured Abdominal Aortic Aneurysm during the COVID-19 Pandemic. Ann Vasc Surg. 2021; 79:114-121. PMC: 8502249. DOI: 10.1016/j.avsg.2021.08.006. View

Eliason J, Hannawa K, Ailawadi G, Sinha I, Ford J, Deogracias M . Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation. 2005; 112(2):232-40. DOI: 10.1161/CIRCULATIONAHA.104.517391. View

Riley C, Teixeira P . Development of symptomatic inflammatory aneurysm treated with endovascular repair in coronavirus disease 2019-infected patient. J Vasc Surg Cases Innov Tech. 2021; 7(2):193-196. PMC: 7985605. DOI: 10.1016/j.jvscit.2021.03.003. View

Kubicek L, Vitasek R, Schwarz D, Staffa R, Strakos P, Polzer S . Biomechanical Rupture Risk Assessment in Management of Patients with Abdominal Aortic Aneurysm in COVID-19 Pandemic. Diagnostics (Basel). 2023; 13(1). PMC: 9818825. DOI: 10.3390/diagnostics13010132. View

Won T, Wood M, Hughes D, Talor M, Ma Z, Schneider J . Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine. 2022; 75:103812. PMC: 8756077. DOI: 10.1016/j.ebiom.2022.103812. View

Kim L, Sweeting M, Armer M, Jacomelli J, Nasim A, Harrison S . Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemic. PLoS One. 2021; 16(6):e0253327. PMC: 8205127. DOI: 10.1371/journal.pone.0253327. View

Selway W, Stenson K, Holt P, Loftus I . Willingness of patients to attend abdominal aortic aneurysm surveillance: The implications of COVID-19 on restarting the National Abdominal Aortic Aneurysm Screening Programme. Br J Surg. 2020; 107(13):e646-e647. PMC: 7537298. DOI: 10.1002/bjs.12059. View

Tayal S, Bhatnagar S . Role of molecular mimicry in the SARS-CoV-2-human interactome for pathogenesis of cardiovascular diseases: An update to ImitateDB. Comput Biol Chem. 2023; 106:107919. DOI: 10.1016/j.compbiolchem.2023.107919. View

10.

Faggioli G, Chakfe N, Imray C . Maintaining Safe Elective Aneurysm Surgery in the COVID-19 Era. Eur J Vasc Endovasc Surg. 2021; 62(5):675-677. PMC: 8249703. DOI: 10.1016/j.ejvs.2021.06.033. View

11.

Loo J, Spittle D, Newnham M . COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax. 2021; 76(4):412-420. DOI: 10.1136/thoraxjnl-2020-216243. View

12.

Kuba K, Imai Y, Ohto-Nakanishi T, Penninger J . Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010; 128(1):119-28. PMC: 7112678. DOI: 10.1016/j.pharmthera.2010.06.003. View

13.

Bozzani A, Arici V, Tavazzi G, Mojoli F, Bruno R, Sterpetti A . Acute Thrombosis of Lower Limbs Arteries in the Acute Phase and After Recovery From COVID19. Ann Surg. 2021; 273(4):e159-e160. PMC: 7959866. DOI: 10.1097/SLA.0000000000004700. View

14.

Meher A, Spinosa M, Davis J, Pope N, Laubach V, Su G . Novel Role of IL (Interleukin)-1β in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms. Arterioscler Thromb Vasc Biol. 2018; 38(4):843-853. PMC: 5864548. DOI: 10.1161/ATVBAHA.117.309897. View

15.

Plana E, Oto J, Medina P, Fernandez-Pardo A, Miralles M . Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review. Thromb Res. 2020; 194:200-208. DOI: 10.1016/j.thromres.2020.07.039. View

16.

Al-Samarneh T, Janho K, Jalokh M, Abudayyeh R, Al-Doud M, Anakrih B . Ruptured abdominal aortic aneurysm treated with open surgical repair (OSR) of a patient with active COVID-19 infection: A case report. Int J Surg Case Rep. 2022; 96:107288. PMC: 9170588. DOI: 10.1016/j.ijscr.2022.107288. View

17.

Tuculeanu G, Barbu E, Lazar M, Chitu-Tisu C, Moisa E, Negoita S . Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19. J Clin Med. 2023; 12(2). PMC: 9866352. DOI: 10.3390/jcm12020601. View

18.

Petzold T, Zhang Z, Ballesteros I, Saleh I, Polzin A, Thienel M . Neutrophil "plucking" on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity. 2022; 55(12):2285-2299.e7. PMC: 9767676. DOI: 10.1016/j.immuni.2022.10.001. View

19.

Gao J, Cao H, Hu G, Wu Y, Xu Y, Cui H . The mechanism and therapy of aortic aneurysms. Signal Transduct Target Ther. 2023; 8(1):55. PMC: 9898314. DOI: 10.1038/s41392-023-01325-7. View

20.

Xu B, Li G, Guo J, Ikezoe T, Kasirajan K, Zhao S . Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms. J Vasc Surg. 2021; 74(5):1740-1751. PMC: 7944865. DOI: 10.1016/j.jvs.2021.01.051. View